We spoke to Dr Matthew Kahn, Consultant Cardiologist (Heart Failure & Complex Devices), Cheshire & Merseyside Network Lead for Heart Failure & Device Therapy, Liverpool Heart and Chest Hospital, UK.
We spoke to HFPN member Ekaterini Lambrinou, a Professor of Nursing at Cyprus University of Technology.
We speak to HFPN member Marc Bains, Co-Founder of the HeartLife Foundation, Canada
On 3 December, the Council of the EU approved conclusions on cardiovascular health, marking a significant step toward improving outcomes in Europe. This milestone publication delivers long-awaited political commitment to address the burden of cardiovascular disease (CVD).
We speak to HFPN member Dr Loreena Hill, who is a Reader in the School of Nursing & Midwifery at Queen’s University Belfast in Northern Ireland.
We speak to HFPN member Winfried Klausnitzer, who is Founder and Chair of patient organisation Herzschwäche Deutschland e.V. (Heart Failure Germany).
The Hungarian Society of Cardiology Working Group on Heart Failure and Myocardial Diseases, with support from the HFPN, hosted an event to launch a policy submission on opportunities to reduce the burden of heart failure in Europe.
We speak to HFPN member Dr Teresa Castiello, who is a consultant cardiologist at the Homerton Hospital NHS Foundation Trust in the UK.
We speak to HFPN member Cristina Enjuanes, Coordinator of the Community Heart Unit at the Hospital de Bellvitge, L’Hospitalet de Llobregat, Spain
We speak to HFPN member Carys Barton, Heart Failure Nurse Consultant at the Imperial College Healthcare Trust and Chair Elect of the British Society for Heart Failure.
We speak to HFPN member Cristos Lionis, Professor Emeritus of General Practice and Primary Health Care at the School of Medicine at the University of Crete in Greece.
We speak to HFPN member Anke Kampmann, who is a Heart Failure Advanced Practice Nurse at the Heartcentre Trier at the Hospital of the Brothers of Mercy Trier in Germany.
Heart failure is prevalent in Germany, but is under-recognised. Key stakeholders came together at the German Heart Failure Roundtable to discuss the need for policy change and comprehensive investment in heart failure care.
The Heart Failure Policy Summit will offer an opportunity for heart failure advocates to build alliances across disease areas and link to broader health policy agendas.
Taking the form of four virtual sessions held in October and November, the 2022 Heart Failure Policy Summit will address how we can engage with policymakers and leaders to improve care for the millions of people living with heart failure across Europe.
The Heart Failure Policy Network (HFPN) has launched Spotlight on cancer treatment and heart failure, which highlights the need for integrated care and collaboration between oncology and cardiology services.
The Heart Failure Policy Network has launched the ‘Spotlight on worsening heart failure’, which highlights the actions that decision-makers can take to prevent heart failure hospitalisations.
After two years of disruption, many countries are lifting COVID-19 restrictions. We have been talking with the HFPN community about the key lessons learnt from the pandemic and how they can help shape the future of heart failure care.
What links a dog dressed as a fairy, an MP with a new heart, and Michelle Obama? Network Director Joe Farrington-Douglas reflects on what we learned from the inaugural 2021 Heart Failure Policy Summit.
The Heart Failure Policy Network is delighted to announce the launch of the Trailblazers Hub, a new online resource showcasing examples of inspirational system transformation and political advocacy in heart failure.
Watch the full webinar ‘Freedom from heart failure: reimagining cardiac services in England’ which was co-hosted by the Heart Failure Policy Network (HFPN) and the British Society for Heart Failure (BSH).
The PHSSR summit will bring together the academic, public and private sectors to share insights on improving health system sustainability and resilience.
This video series examines the heart failure policy priorities different stakeholder would like to see, including healthcare professionals, patient advocates and policymakers.